Karrasch M, Pfister W, Edel B, Stallmach A, Hagel S, Hochhaus A, Rödel J: Campylobacter jejuni ssp. jejuni bacteraemia in a patient with BCR-ABL-positive chronic myelogenous leukaemia in remission on dasatinib therapy Open Access. JMM Case Reports Volume 2, Issue 6, First Published: 13 December 2015 https://doi.org/10.1099/jmmcr.0.005001
Kalmanti L, Saussele S, Lauseker M, Müller MC, Dietz CT, Heinrich L, Hanfstein B, Proetel U, Fabarius U, Krause SW, Rinaldetti S , Dengler J , Falge C , Oppliger-Leibundgut E, Burchert A, Neubauer A, Kanz L , Stegelmann F , Pfreundschuh M , Spiekermann K , Scheid C , Pfirrmann M , Hochhaus A , Hasford J, Hehlmann R : Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV. Leukemia. 2015;29(5):1123-1132. doi:10.1038/leu.2015.36 PMID: 25676422
Kiani A, Kuhlencordt P, Hochhaus A, Tesch H, Saussele S, Le Coutre P: Prävention und Management kardiovaskulärer Erkrankungen mit Nilotinib. Onkologe 21, 724–731 (2015). https://doi.org/10.1007/s00761-015-2990-5
Hilgendorf I, Hochhaus A: Spätfolgen der allogenen Blutstammzelltransplantation. Onkologe 2015 · 21:433–442, DOI 10.1007/s00761-015-2923-3, © Springer-Verlag Berlin Heidelberg 2015
Cross NC, Müller MC, Hochhaus A. Response to Ho-Wan Ip and Chi-Chiu. Leukemia. 2015;29(7):1619. doi:10.1038/leu.2015.97. PMID: 25999150
Cross NC, White HE, Colomer D, Ehrencrona H, Foroni L, Gottardi E, Lange T, Lion T, Machova Polakova K, Dulucq S, Martinelli G, Oppliger Leibundgut E, Pallisgaard N, Barbany G, Sacha T, Talmaci R, Izzo B, Saglio G, Pane F, Müller MC, Hochhaus A: Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia, Leukemia accepted article preview 5 February 2015; doi: 10.1038/leu.2015.29. PMID: 25652737
Guntinas-Lichius O, Wendt TG, Buentzel J, Esser D, Böger D, Mueller AH, Piesold JU, Schultze-Mosgau S, Schlattmann P, Schmalenberg H: Incidence, treatment, and outcome of parotid carcinoma, 1996-2011: a population-based study in Thuringia, Germany. J Cancer Res Clin Oncol. 2015;141(9):1679-1688. doi:10.1007/s00432-015-1961-y. PMID: 25800621
Fabarius A, Kalmanti L, Dietz CT, Lauseker M, Rinaldetti S, Haferlach C, Göhring G, Schlegelberger B, Jotterand M, Hanfstein B, Seifarth W, Hänel M, Köhne CH, Lindemann HW, Berdel WE, Staib P , Müller MC, Proetel U, Balleisen L, Goebeler ME, Dengler J, Falge C, Kanz L, Burchert A, Kneba M 18 , Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Brümmendorf TH, Edinger M, Hofmann W, Pfirrmann M, Hasford J, Krause S, Hochhaus A, Saußele S, Hehlmann R, SAKK and the German CML Study Group: Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML. Ann Hematol. 2015;94(12):2015-2024. doi:10.1007/s00277-015-2494-9. PMID: 26385387
Schrenk KG, Schnetzke U, Stegemann K, von Lilienfeld-Toal M, Hochhaus A, Scholl S. Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia. J Cancer Res Clin Oncol. 2015;141(9):1661-1668. doi:10.1007/s00432-015-1962-x. PMID: 25800622
Eigendorff E, Hochhaus A: Akute Leukämien des Erwachsenen. Pathologe 2015 · 36:503–519, DOI 10.1007/s00292-015-0087-y. Online publiziert: 28. August 2015
Maschmeyer G, Mügge LO, Kämpfe D, Kreibich U, Wilhelm S, Aßmann M, Schwarz M, Kahl C, Köhler S, Grobe N, Niederwieser D: A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010-2012. J Cancer Res Clin Oncol. 2015;141(9):1639-1644. doi:10.1007/s00432-015-1954-x PMID: 25773126
Qi Tia, James L. Smart, Joachim H. Clement, Yingming Wang, Alex Derkatch, Harald Schubert, Michael V. Danilchik, Daniel L. Marks, Lev M. Fedorov: RHEB1 expression in embryonic and postnatal mouse. Histochem Cell Biol, DOI 10.1007/s00418-015-1394-3. PMID: 26708151 [PubMed - as supplied by publisher]
La Rosée P: First prospective clinical trial in adult HLH. Blood. 2015 Nov 5;126(19):2169-71. doi: 10.1182/blood-2015-09-666503. PMID:26542249 [PubMed - in process]
Max Desole, Karin G. Schrenk, Ulf Schnetzke, Andreas Hochhaus, Sebastian Scholl: Detection of Enterococcus spp. in bronchoalveolar lavage fluid of patients with high‑risk neutropenia: May it be ignored? J Cancer Res Clin Oncol DOI 10.1007/s00432-015-2084-1. PMID:26621154
Michael W Deininger, J Graeme Hodgson, Neil P Shah, Jorge E Cortes, Dong-Wook Kim, Franck E Nicolini, Moshe Talpaz, Michele Baccarani, Martin C Müller, Jin Li, Wendy T. Parker, Stephanie Lustgarten, Tim Clackson, Frank G Haluska, Francois Guilhot, Hagop M Kantarjian, Simona Soverini, Andreas Hochhaus, Timothy P Hughes, Victor M Rivera, and Susan Branford: Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients. Blood First Edition Paper, prepublished online November 24, 2015; DOI 10.1182/blood-2015-08-660977. PMID: 26603839
Gräfe, C., Weidner, A., von der Lühe, M., Bergemann, C., Schacher, F.H., Clement, J.H. und Dutz, S: Intentional formation of a protein corona on nanoparticles: Serumconcentration affects protein corona mass, surface charge, and nano-particle–cell interaction. J Biochem Cell Biol (2015), http://dx.doi.org/10.1016/j.biocel.2015.11.005
A Gratwohl, M Pfirrmann, A Zander, N Kröger, D Beelen, J Novotny, C Nerl, C Scheid, K Spiekermann, J Mayer, HG Sayer, C Falge, D Bunjes, H Döhner, A Ganser, I Schmidt-Wolf, R Schwerdtfeger, H Baurmann, R Kuse, N Schmitz, A Wehmeier, J Th Fischer, AD Ho, M Wilhelm, M-E Goebeler, HW Lindemann, M Bormann, B Hertenstein, G Schlimok, GM Baerlocher, C Aul, M Pfreundschuh, M Fabian, P Staib, M Edinger, M Schatz, A Fauser, R Arnold, T Kindler, G Wulf, A Rosselet, A Hellmann, E Schäfer, O Prümmer, M Schenk, J Hasford, H Heimpel, DK Hossfeld, H-J Kolb, G Büsche, C Haferlach, S Schnittger, MC Müller, A Reiter, U Berger, S Saußele, A Hochhaus, and R Hehlmann: Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia advance online publication, 20 November 2015; doi:10.1038/leu.2015.281. PMID: 26464170
A Hochhaus, G Rosti, NCP Cross, JL Steegmann, P le Coutre, G Ossenkoppele, L Petrov, T Masszi, A Hellmann, L Griskevicius, W Wiktor-Jedrzejczak, D Rea, D Coriu, TH Brümmendorf, K Porkka, G Saglio, G Gastl, MC Müller, P Schuld, P Di Matteo, A Pellegrino, L Dezzani, F-X Mahon, M Baccarani and FJ Giles: Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study. Leukemia. 2015 Oct 6. doi: 10.1038/leu.2015.270. PMID: 26437782
Karin G. Schrenk, Janina Frosinski, Sebastian Scholl, Sylvia Otto, Paul La Rosée, Andreas Hochhaus, Mathias W. Pletz: Successful treatment of neutropenic MRSA bacteremia with septic superior vena cava thrombus and cerebral embolism using high-dose daptomycin. Ann Hematol DOI 10.1007/s00277-015-2526-5, PMID: 26490881
Christian Pfrepper, Anne Klink, Gerhard Behre, Thomas Schenk,·Georg‑Nikolaus Franke, Madlen Jentzsch, Sebastian Schwind, Haifa‑Kathrin Al‑Ali, Andreas Hochhaus, Dietger Niederwieser, Herbert Gottfried Sayer: Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced‑intensity conditioning and allogeneic stem cell transplantation. J Cancer Res Clin Oncol DOI 10.1007/s00432-015-2050-y, PMID: 26424692
C. Kahl, R. Krahl, C. Becker, H. K. Al‑Ali, H. G. Sayer, A. Schulze, M. Herold, M. Hänel, S. Scholl, A. Hochhaus, L. Uharek, G. Maschmeyer, D. Haehling, C. Junghanß, N. Peter, D. Kämpfe, E. Kettner, T. Heinicke, T. Fischer, U. Kreibich, H.‑H. Wolf, D. Niederwieser: Long‑term follow‑up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO). J Cancer Res Clin Oncol, DOI 10.1007/s00432-015-2045-8, PMID: 26407768
Matthias Karrasch, Wolfgang Pfister, Birgit Edel,Andreas Stallmach, Stefan Hagel, Andreas Hochhaus and Jürgen Rödel: Campylobacter jejuni ssp. jejuni bacteraemia in a patient with BCR-ABL-positive chronic myelogenous leukaemia in remission on dasatinib therapy. JMM Case Reports (2015) DOI 10.1099/jmmcr.0.000083
K Wenn, L Tomala, S Wilop, L Vankann, C Hasenbank, O Frank, A Hochhaus, F J Giles, T Lange, M C Müller, S Koschmieder, F Beier, P Ziegler, T H Brümmendorf, Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib, Leukemia accepted article preview 15 September 2015; doi: 10.1038/leu.2015.245.PMID:26369986
Andreas Hochhaus, Michele Baccarani, Francis J. Giles, Philipp D. le Coutre, Martin C. Müller, Andreas Reiter, Helene Santanastasio, Mimi Leung, Steven Novick, Hagop M.Kantarjian: Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study. J Cancer Res Clin Oncol (2015) 141:2047–2060 DOI 10.1007/s00432-015-1988-0 PMID: 26002753 [PubMed - in process]
E. Eigendorff, A. Hochhaus: Akute Leukämien des Erwachsenen. Pathologe. 2015 Aug 28. [Epub ahead of print] PMID: 26314268
Karin G. Schrenk, Kathrin Katenkamp, Jörg Felber, Lars-Olof Mügge, Andreas Hochhaus, Sebastian Scholl: Lower gastrointestinal bleeding in a patient with Crohn’s disease and plasma cell leukemia in remission. Ann Hematol. 2015 Aug 21. [Epub ahead of print], PMID: 26289474
Richter ME, Neugebauer S, Engelmann F, Hagel S, Ludewig K, La Rosée P, Sayer HG, Hochhaus A, von Lilienfeld-Toal M, Bretschneider T, Pausch C, Engel C, Brunkhorst FM, Kiehntopf M.: Biomarker candidates for the detection of an infectious etiology of febrile neutropenia. Infection. 2015 Aug 15. [Epub ahead of print], PMID: 26275448
Kai Lehmberg, Kim E. Nichols, Jan-Inge Henter, Michael Girschikofsky, Tatiana Greenwood, Michael Jordan, Ashish Kumar, Milen Minkov, Paul La Rosée, and Sheila Weitzmann, for the Study Group on Hemophagocytic Lymphohistiocytosis Subtypes of the Histiocyte Society: Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. doi:10.3324/haematol.2015.123562. PMID: 26314082
U. Wehkamp, D. Glaeser, I. Oschlies, I. Hilgendorf, W. Klapper, M. Weichenthal: Successful stem cell transplantation in a patient with primary cutaneous aggressive cytotoxic epidermotropic CD8 + T-Cell lymphoma. British Journal of Dermatology (2015) DOI: 10.1111/bjd.13792. PMID: 25816848
A Weidner, C Gräfe, M von der Lühe, H Remmer, J H Clement, D Eberbeck, F Ludwig, R Müller, F H Schacher and S Dutz: Preparation of Core-Shell Hybrid Materials by Producing a Protein Corona Around Magnetic Nanoparticles. Nanoscale Research Letters (2015) 10:282 DOI 10.1186/s11671-015-0992-2. PMID: 26153125
T P Hughes, G Saglio, A Quinta´s-Cardama,MJ Mauro, D-W Kim, J H Lipton, M B Bradley-Garelik, J Ukropec, A Hochhaus: BCR-ABL1mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase, Leukemia; doi: 10.1038/leu.2015.168. PMID: 26118315
Fernandez-Cuesta L, Sun R, Menon R, George J, Lorenz S, Meza-Zepeda LA, Peifer M, Plenker D, Heuckmann JM, Leenders F, Zander T, Dahmen I, Koker M, Schöttle J, Ullrich RT, Altmüller J, Becker C, Nürnberg P, Seidel H, Böhm D, Göke F, Ansén S, Russell PA, Wright GM, Wainer Z, Solomon B, Petersen I, Clement JH, Sänger J, Brustugun OT, Helland Å, Solberg S, Lund-Iversen M, Buettner R, Wolf J, Brambilla E, Vingron M, Perner S, Haas SA, Thomas RK: Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data. Genome Biol. (2015) Jan 5;16:7. doi: 10.1186/s13059-014-0558-0. PMID: 25650807
von der Lühe M, Günther U, Weidner A, Gräfe C, Clement HJ, Dutz S, Schacher FH: SPION@polydehydroalanine hybrid particles. RSC Adv., 2015, 5, 31920
DOI: 10.1039/C5RA01737H
Steinbach C1, Steinbrücker C, Pollok S, Walther K, Clement JH, Chen Y, Petersen I, Cialla-May D, Weber K, Popp J: KRAS mutation screening by chip-based DNA hybridization - a further step towards personalized oncology. Analyst. 2015 Apr 21;140(8):2747-54. doi: 10.1039/c4an02086c. Epub 2015 Feb 23.
PMID: 25706807